“The results from these Phase 3 trials support the clinical benefit of PT027, an albuterol/budesonide rescue inhaler, which has the potential to be a first-in-class treatment approach that can ...

One of the primary differences between asthma inhalers is whether they are meant for quick relief of an asthma attack ...

Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease ...